메뉴 건너뛰기




Volumn 14, Issue 12, 2008, Pages 3761-3767

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

EID: 52449114074     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4806     Document Type: Article
Times cited : (96)

References (37)
  • 2
    • 0028113345 scopus 로고
    • A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
    • Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
    • (1994) Science , vol.266 , pp. 66-71
    • Miki, Y.1    Swensen, J.2    Shattuck-Eidens, D.3
  • 3
    • 0006713602 scopus 로고
    • Identification of the breast cancer susceptibility gene BRCA2
    • Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
    • (1995) Nature , vol.378 , pp. 789-792
    • Wooster, R.1    Bignell, G.2    Lancaster, J.3
  • 4
    • 17344365851 scopus 로고    scopus 로고
    • Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
    • Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62:676-89.
    • (1998) Am J Hum Genet , vol.62 , pp. 676-689
    • Ford, D.1    Easton, D.F.2    Stratton, M.3
  • 5
    • 0033365227 scopus 로고    scopus 로고
    • The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes
    • Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 1999;65:1021 -9.
    • (1999) Am J Hum Genet , vol.65 , pp. 1021-1029
    • Gayther, S.A.1    Russell, P.2    Harrington, P.3    Antoniou, A.C.4    Easton, D.F.5    Ponder, B.A.6
  • 6
    • 37049023252 scopus 로고    scopus 로고
    • Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    • Ramus SJ, Harrington PA, Pye C, et al. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Hum Mutat 2007;28:1207-15.
    • (2007) Hum Mutat , vol.28 , pp. 1207-1215
    • Ramus, S.J.1    Harrington, P.A.2    Pye, C.3
  • 7
    • 0037033733 scopus 로고    scopus 로고
    • A comprehensive model for familial breast cancer incorporating BRCA1 BRCA2 and other genes
    • Antoniou AC, Pharoah PD, McMullan G, et al. A comprehensive model for familial breast cancer incorporating BRCA1 BRCA2 and other genes. Br J Cancer 2002;86:76-83.
    • (2002) Br J Cancer , vol.86 , pp. 76-83
    • Antoniou, A.C.1    Pharoah, P.D.2    McMullan, G.3
  • 8
    • 0031003498 scopus 로고    scopus 로고
    • Contribution of BRCA1 mutations to ovarian cancer
    • Stratton JF, Gayther SA, Russell P, et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997;336:1125-30.
    • (1997) N Engl J Med , vol.336 , pp. 1125-1130
    • Stratton, J.F.1    Gayther, S.A.2    Russell, P.3
  • 9
    • 0031958466 scopus 로고    scopus 로고
    • BRCA1 BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing
    • Rubin SC, Blackwood MA, Bandera C, et al. BRCA1 BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol 1998; 178:670-7.
    • (1998) Am J Obstet Gynecol , vol.178 , pp. 670-677
    • Rubin, S.C.1    Blackwood, M.A.2    Bandera, C.3
  • 10
    • 0032945329 scopus 로고    scopus 로고
    • Germ-line BRCA1 alterations in a population-based series of ovarian cancer cases
    • Janezic SA, Ziogas A, Krumroy LM, et al. Germ-line BRCA1 alterations in a population-based series of ovarian cancer cases. Hum Mol Genet 1999;8: 889-97.
    • (1999) Hum Mol Genet , vol.8 , pp. 889-897
    • Janezic, S.A.1    Ziogas, A.2    Krumroy, L.M.3
  • 11
    • 0035098503 scopus 로고    scopus 로고
    • Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
    • Risen HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700-10.
    • (2001) Am J Hum Genet , vol.68 , pp. 700-710
    • Risen, H.A.1    McLaughlin, J.R.2    Cole, D.E.3
  • 12
    • 29144509766 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
    • Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005;104:2807 -16.
    • (2005) Cancer , vol.104 , pp. 2807-2816
    • Pal, T.1    Permuth-Wey, J.2    Betts, J.A.3
  • 13
    • 33845654907 scopus 로고    scopus 로고
    • Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
    • Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006;98:1694 - 706.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1694-1706
    • Risch, H.A.1    McLaughlin, J.R.2    Cole, D.E.3
  • 14
    • 0034948376 scopus 로고    scopus 로고
    • BRCA1 and BRCA1 mutations among 233 unselected Finnish ovarian carcinoma patients
    • Sarantaus L,Vahteristo P, Bloom E, et al. BRCA1 and BRCA1 mutations among 233 unselected Finnish ovarian carcinoma patients. Eur J Hum Genet 2001;9: 424-30.
    • (2001) Eur J Hum Genet , vol.9 , pp. 424-430
    • Sarantaus, L.1    Vahteristo, P.2    Bloom, E.3
  • 15
    • 9444248601 scopus 로고    scopus 로고
    • High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients
    • Johannesdottir G, Gudmundsson J, Bergthorsson JT, et al. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res1996;56:3663-5.
    • Cancer Res1996;56 , pp. 3663-3665
    • Johannesdottir, G.1    Gudmundsson, J.2    Bergthorsson, J.T.3
  • 16
    • 0033031573 scopus 로고    scopus 로고
    • Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA
    • Dorum A, Hovig E, Tropé C, Inganas M, Møiler P. Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 1999;35;779-81.
    • (1999) Eur J Cancer , vol.35 , pp. 779-781
    • Dorum, A.1    Hovig, E.2    Tropé, C.3    Inganas, M.4    Møiler, P.5
  • 17
    • 0034813329 scopus 로고    scopus 로고
    • A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer
    • Einbeigi Z, Bergman A, Kindblom LG, et al. A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 2001;37:1904-9.
    • (2001) Eur J Cancer , vol.37 , pp. 1904-1909
    • Einbeigi, Z.1    Bergman, A.2    Kindblom, L.G.3
  • 18
    • 1642554820 scopus 로고    scopus 로고
    • One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: Results of a prospective study in southern Sweden
    • Malander S, Ridderheim M, Masback A, et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in southern Sweden. Eur J Cancer 2004;40:422-8.
    • (2004) Eur J Cancer , vol.40 , pp. 422-428
    • Malander, S.1    Ridderheim, M.2    Masback, A.3
  • 19
    • 33645648785 scopus 로고    scopus 로고
    • M, Kruger Kjaer S, Gayther SA Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention
    • Søgaard M, Kruger Kjaer S, Gayther SA Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 2006;85:93-105.
    • (2006) Acta Obstet Gynecol Scand , vol.85 , pp. 93-105
    • Søgaard1
  • 20
    • 0034990616 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
    • Bergthorsson JT, Ejlertsen B, Olsen JH, et al. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 2001;38:361-8.
    • (2001) J Med Genet , vol.38 , pp. 361-368
    • Bergthorsson, J.T.1    Ejlertsen, B.2    Olsen, J.H.3
  • 21
    • 0031035045 scopus 로고    scopus 로고
    • A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17
    • Puget N,Torchard D, Serova-Sinilnikova OM, et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 1997;57:828-31.
    • (1997) Cancer Res , vol.57 , pp. 828-831
    • Puget, N.1    Torchard, D.2    Serova-Sinilnikova, O.M.3
  • 22
    • 16944363592 scopus 로고    scopus 로고
    • BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
    • Petrij-Bosch A, PeelenT, van Vliet M, et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997;17: 341 -5.
    • (1997) Nat Genet , vol.17 , pp. 341-345
    • Petrij-Bosch, A.1    PeelenT2    van Vliet, M.3
  • 23
    • 18744401644 scopus 로고    scopus 로고
    • Genomic rearrangements in the BRCA1 and BRCA2 genes
    • Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005;25:415-22.
    • (2005) Hum Mutat , vol.25 , pp. 415-422
    • Mazoyer, S.1
  • 25
    • 11144354423 scopus 로고    scopus 로고
    • Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
    • Lakhani SR. Manek S, Penault-Llorca F, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 2004;10:2473-81.
    • (2004) Clin Cancer Res , vol.10 , pp. 2473-2481
    • Lakhani, S.R.1    Manek, S.2    Penault-Llorca, F.3
  • 26
    • 10544220023 scopus 로고    scopus 로고
    • Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
    • Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N Engl J Med 1996; 335:1413-6.
    • (1996) N Engl J Med , vol.335 , pp. 1413-1416
    • Rubin, S.C.1    Benjamin, I.2    Behbakht, K.3
  • 27
    • 0034600109 scopus 로고    scopus 로고
    • Clinicopatho-logic features of BRCA-linked and sporadic ovarian cancer
    • Boyd J, Sonoda Y, Federici MG, et al. Clinicopatho-logic features of BRCA-linked and sporadic ovarian cancer. JAMA 2000;283:2260-5.
    • (2000) JAMA , vol.283 , pp. 2260-2265
    • Boyd, J.1    Sonoda, Y.2    Federici, M.G.3
  • 28
    • 17444448154 scopus 로고    scopus 로고
    • Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden
    • Johannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 1998;16:398-404.
    • (1998) J Clin Oncol , vol.16 , pp. 398-404
    • Johannsson, O.T.1    Ranstam, J.2    Borg, A.3    Olsson, H.4
  • 30
    • 7544222400 scopus 로고    scopus 로고
    • Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer
    • Glud E, Kjaer SK, Thomsen BL, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164: 2253-9.
    • (2004) Arch Intern Med , vol.164 , pp. 2253-2259
    • Glud, E.1    Kjaer, S.K.2    Thomsen, B.L.3
  • 31
    • 0031612929 scopus 로고    scopus 로고
    • Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group
    • Antonarakis SE; Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998;11:1-3.
    • (1998) Hum Mutat , vol.11 , pp. 1-3
    • Antonarakis, S.E.1
  • 32
    • 17944388284 scopus 로고
    • Breast cancer information on the Web
    • Friend S, Borresen AL, Brody L, et al. Breast cancer information on the Web. Nat Genet 1995;11:238-9.
    • (1995) Nat Genet , vol.11 , pp. 238-239
    • Friend, S.1    Borresen, A.L.2    Brody, L.3
  • 34
    • 33750353461 scopus 로고    scopus 로고
    • Predicting the effects of amino acid substitutions on protein function
    • Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006;7:61 -80.
    • (2006) Annu Rev Genomics Hum Genet , vol.7 , pp. 61-80
    • Ng, P.C.1    Henikoff, S.2
  • 35
    • 33644847172 scopus 로고    scopus 로고
    • Prediction of protein stability changes for single-site mutations using support vector machines
    • Cheng J, Randall A, Baldi P. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 2006;62: 1125-32.
    • (2006) Proteins , vol.62 , pp. 1125-1132
    • Cheng, J.1    Randall, A.2    Baldi, P.3
  • 37
    • 0038744296 scopus 로고    scopus 로고
    • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
    • Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
    • (2003) Am J Hum Genet , vol.72 , pp. 1117-1130
    • Antoniou, A.1    Pharoah, P.D.2    Narod, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.